Abstract

Human serum albumin (HSA) is the frontline antioxidant protein in blood with established anti-inflammatory and anticoagulation functions. Here we report that COVID-19-induced oxidative stress inflicts structural damages to HSA and is linked with mortality outcome in critically ill patients. We recruited 39 patients who were followed up for a median of 12.5 days (1-35 days), among them 23 had died. Analyzing blood samples from patients and healthy individuals (n=11), we provide evidence that neutrophils are major sources of oxidative stress in blood and that hydrogen peroxide is highly accumulated in plasmas of non-survivors. We then analyzed electron paramagnetic resonance (EPR) spectra of spin labelled fatty acids (SLFA) bound with HSA in whole blood of control, survivor, and non-survivor subjects (n=10-11). Non-survivor' HSA showed dramatically reduced protein packing order parameter, faster SLFA correlational rotational time, and smaller S/W ratio (strong-binding/weak-binding sites within HSA), all reflecting remarkably fluid protein microenvironments. Following loading/unloading of 16-DSA we show that transport function of HSA maybe impaired in severe patients. Stratified at the means, Kaplan–Meier survival analysis indicated that lower values of S/W ratio and accumulated H2O2 in plasma significantly predicted in-hospital mortality (S/W≤0.15, 81.8% (18/22) vs. S/W>0.15, 18.2% (4/22), p=0.023; plasma [H2O2]>8.6 mM, 65.2% (15/23) vs. 34.8% (8/23), p=0.043). When we combined these two parameters as the ratio ((S/W)/[H2O2]) to derive a risk score, the resultant risk score lower than the mean (< 0.019) predicted mortality with high fidelity (95.5% (21/22) vs. 4.5% (1/22), logrank c2 = 12.1, p=4.9x10-4). The derived parameters may provide a surrogate marker to assess new candidates for COVID-19 treatments targeting HSA replacements and/or oxidative stress.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Raw data collected and used to produce all figures and tables are available on Dyrad (https://doi.org/10.5061/dryad.cnp5hqc4q).

The following data sets were generated

Article and author information

Author details

  1. Mohamed A Badawy

    Research Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1691-0167
  2. Basma A Yasseen

    Research Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  3. Riem M El-Messiery

    Faculty of Medicine, Cairo University, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  4. Engy A Abdel-Rahman

    Research Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  5. Aya A Elkhodiry

    Research Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5684-0242
  6. Azza G Kamel

    Research Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  7. Hajar El-sayed

    Research Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  8. Asmaa M Shedra

    Research Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  9. Rehab Hamdy

    Research Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  10. Mona Zidan

    Research Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  11. Diaa Al-Raawi

    Research Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  12. Mahmoud Hammad

    Pediatric Oncology Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1677-0360
  13. Nahla Elsharkawy

    Clinical pathology department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  14. Mohamed El Ansary

    Department of Intensive Care, Faculty of Medicine, Cairo University, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  15. Ahmed Al-Halfawy

    Department of Pulmonary Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  16. Alaa Elhadad

    Pediatric Oncology Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  17. Ashraf Hatem

    Department of Chest Diseases, Faculty of Medicine, Cairo University, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  18. Sherif Abouelnaga

    Pediatric Oncology Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    Competing interests
    The authors declare that no competing interests exist.
  19. Laura L Dugan

    Division of Geriatric Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.
  20. Sameh Saad Ali

    Research Department, Children's Cancer Hospital Egypt 57357, Cairo, Egypt
    For correspondence
    sameh.ali@57357.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0339-6106

Funding

The Association of Friends of the National Cancer Institute (COVID-SA)

  • Sameh Saad Ali

The Children's Cancer Hospital Egypt (SA-Start up)

  • Sameh Saad Ali

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Written informed consents were obtained from participants in accordance with the principles of the Declaration of Helsinki. For COVID-19 and control blood/plasma collection, Children's Cancer Hospital's Institutional Review Board (IRB) has evaluated the study design and protocol, IRB number 31-2020 issued on July 6, 2020.

Copyright

© 2021, Badawy et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,754
    views
  • 202
    downloads
  • 31
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Mohamed A Badawy
  2. Basma A Yasseen
  3. Riem M El-Messiery
  4. Engy A Abdel-Rahman
  5. Aya A Elkhodiry
  6. Azza G Kamel
  7. Hajar El-sayed
  8. Asmaa M Shedra
  9. Rehab Hamdy
  10. Mona Zidan
  11. Diaa Al-Raawi
  12. Mahmoud Hammad
  13. Nahla Elsharkawy
  14. Mohamed El Ansary
  15. Ahmed Al-Halfawy
  16. Alaa Elhadad
  17. Ashraf Hatem
  18. Sherif Abouelnaga
  19. Laura L Dugan
  20. Sameh Saad Ali
(2021)
Neutrophil-mediated oxidative stress and albumin structural damage predict COVID-19-associated mortality
eLife 10:e69417.
https://doi.org/10.7554/eLife.69417

Share this article

https://doi.org/10.7554/eLife.69417

Further reading

    1. Immunology and Inflammation
    Arijit Chakraborty, Arunava Bandyopadhaya ... Laurence G Rahme
    Research Article

    How bacterial pathogens exploit host metabolism to promote immune tolerance and persist in infected hosts remains elusive. To achieve this, we show that Pseudomonas aeruginosa (PA), a recalcitrant pathogen, utilizes the quorum sensing (QS) signal 2’-aminoacetophenone (2-AA). Here, we unveil how 2-AA-driven immune tolerization causes distinct metabolic perturbations in murine macrophages’ mitochondrial respiration and bioenergetics. We present evidence indicating that these effects stem from decreased pyruvate transport into mitochondria. This reduction is attributed to decreased expression of the mitochondrial pyruvate carrier (Mpc1), which is mediated by diminished expression and nuclear presence of its transcriptional regulator, estrogen-related nuclear receptor alpha (Esrra). Consequently, Esrra exhibits weakened binding to the Mpc1 promoter. This outcome arises from the impaired interaction between Esrra and the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (Ppargc1a). Ultimately, this cascade results in diminished pyruvate influx into mitochondria and, consequently reduced ATP production in tolerized murine and human macrophages. Exogenously added ATP in infected macrophages restores the transcript levels of Mpc1 and Esrra and enhances cytokine production and intracellular bacterial clearance. Consistent with the in vitro findings, murine infection studies corroborate the 2-AA-mediated long-lasting decrease in ATP and acetyl-CoA and its association with PA persistence, further supporting this QS signaling molecule as the culprit of the host bioenergetic alterations and PA persistence. These findings unveil 2-AA as a modulator of cellular immunometabolism and reveal an unprecedented mechanism of host tolerance to infection involving the Ppargc1a/Esrra axis in its influence on Mpc1/OXPHOS-dependent energy production and PA clearance. These paradigmatic findings pave the way for developing treatments to bolster host resilience to pathogen-induced damage. Given that QS is a common characteristic of prokaryotes, it is likely that 2-AA-like molecules with similar functions may be present in other pathogens.

    1. Immunology and Inflammation
    Alessandra Machado Araujo, Joseph D Dekker ... Haley O Tucker
    Research Article

    We identified a novel mouse plasmacytoid dendritic cell (pDC) lineage derived from the common lymphoid progenitors (CLPs) that is dependent on expression of Bcl11a. These CLP-derived pDCs, which we refer to as ‘B-pDCs’, have a unique gene expression profile that includes hallmark B cell genes, normally not expressed in conventional pDCs. Despite expressing most classical pDC markers such as SIGLEC-H and PDCA1, B-pDCs lack IFN-α secretion, exhibiting a distinct inflammatory profile. Functionally, B-pDCs induce T cell proliferation more robustly than canonical pDCs following Toll-like receptor 9 (TLR9) engagement. B-pDCs, along with another homogeneous subpopulation of myeloid-derived pDCs, display elevated levels of the cell surface receptor tyrosine kinase AXL, mirroring human AXL+ transitional DCs in function and transcriptional profile. Murine B-pDCs therefore represent a phenotypically and functionally distinct CLP-derived DC lineage specialized in T cell activation and previously not described in mice.